82 related articles for article (PubMed ID: 10714174)
1. [Biosynthesis of heparan sulfate and the tumor suppressor EXT gene family].
Kitagawa H; Sugahara K
Tanpakushitsu Kakusan Koso; 2000 Mar; 45(4):579-86. PubMed ID: 10714174
[No Abstract] [Full Text] [Related]
2. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode alpha 1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis.
Kim BT; Kitagawa H; Tamura J; Saito T; Kusche-Gullberg M; Lindahl U; Sugahara K
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7176-81. PubMed ID: 11390981
[TBL] [Abstract][Full Text] [Related]
3. rib-2, a Caenorhabditis elegans homolog of the human tumor suppressor EXT genes encodes a novel alpha1,4-N-acetylglucosaminyltransferase involved in the biosynthetic initiation and elongation of heparan sulfate.
Kitagawa H; Egusa N; Tamura JI; Kusche-Gullberg M; Lindahl U; Sugahara K
J Biol Chem; 2001 Feb; 276(7):4834-8. PubMed ID: 11121397
[TBL] [Abstract][Full Text] [Related]
4. EXT genes are differentially expressed in bone and cartilage during mouse embryogenesis.
Stickens D; Brown D; Evans GA
Dev Dyn; 2000 Jul; 218(3):452-64. PubMed ID: 10878610
[TBL] [Abstract][Full Text] [Related]
5. The tumor suppressor EXT-like gene EXTL2 encodes an alpha1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region. The key enzyme for the chain initiation of heparan sulfate.
Kitagawa H; Shimakawa H; Sugahara K
J Biol Chem; 1999 May; 274(20):13933-7. PubMed ID: 10318803
[TBL] [Abstract][Full Text] [Related]
6. [Proteoglycan core glycosyltransferases].
Uyama T; Kitagawa H; Sugahara K
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1019-26. PubMed ID: 12807004
[No Abstract] [Full Text] [Related]
7. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic loss of the familial tumor-suppressor gene exostosin-1 (EXT1) disrupts heparan sulfate synthesis in cancer cells.
Ropero S; Setien F; Espada J; Fraga MF; Herranz M; Asp J; Benassi MS; Franchi A; Patiño A; Ward LS; Bovee J; Cigudosa JC; Wim W; Esteller M
Hum Mol Genet; 2004 Nov; 13(22):2753-65. PubMed ID: 15385438
[TBL] [Abstract][Full Text] [Related]
9. [Biosynthesis of the sulfated glycosaminoglycans in relation to human diseases].
Kitagawa H
Seikagaku; 2004 Sep; 76(9):1175-90. PubMed ID: 15524106
[No Abstract] [Full Text] [Related]
10. Hereditary multiple exostoses and heparan sulfate polymerization.
Zak BM; Crawford BE; Esko JD
Biochim Biophys Acta; 2002 Dec; 1573(3):346-55. PubMed ID: 12417417
[TBL] [Abstract][Full Text] [Related]
11. The EXT1/EXT2 tumor suppressors: catalytic activities and role in heparan sulfate biosynthesis.
Senay C; Lind T; Muguruma K; Tone Y; Kitagawa H; Sugahara K; Lidholt K; Lindahl U; Kusche-Gullberg M
EMBO Rep; 2000 Sep; 1(3):282-6. PubMed ID: 11256613
[TBL] [Abstract][Full Text] [Related]
12. The link between heparan sulfate and hereditary bone disease: finding a function for the EXT family of putative tumor suppressor proteins.
Duncan G; McCormick C; Tufaro F
J Clin Invest; 2001 Aug; 108(4):511-6. PubMed ID: 11518722
[No Abstract] [Full Text] [Related]
13. The putative tumor suppressors EXT1 and EXT2 are glycosyltransferases required for the biosynthesis of heparan sulfate.
Lind T; Tufaro F; McCormick C; Lindahl U; Lidholt K
J Biol Chem; 1998 Oct; 273(41):26265-8. PubMed ID: 9756849
[TBL] [Abstract][Full Text] [Related]
14. Mice deficient in Ext2 lack heparan sulfate and develop exostoses.
Stickens D; Zak BM; Rougier N; Esko JD; Werb Z
Development; 2005 Nov; 132(22):5055-68. PubMed ID: 16236767
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of heparan sulfate biosynthetic enzyme machinery and characterization of heparan sulfate structure in Nematostella vectensis.
Feta A; Do AT; Rentzsch F; Technau U; Kusche-Gullberg M
Biochem J; 2009 May; 419(3):585-93. PubMed ID: 19170656
[TBL] [Abstract][Full Text] [Related]
16. A sugar fix for bone tumours?
Stickens D; Evans GA
Nat Genet; 1998 Jun; 19(2):110-1. PubMed ID: 9620760
[No Abstract] [Full Text] [Related]
17. Heparin and heparan sulfate biosynthesis.
Sugahara K; Kitagawa H
IUBMB Life; 2002 Oct; 54(4):163-75. PubMed ID: 12512855
[TBL] [Abstract][Full Text] [Related]
18. Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.
Müller B; Prante C; Gastens M; Kuhn J; Kleesiek K; Götting C
Matrix Biol; 2008 Mar; 27(2):139-49. PubMed ID: 17980567
[TBL] [Abstract][Full Text] [Related]
19. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
Hall CR; Cole WG; Haynes R; Hecht JT
Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
[TBL] [Abstract][Full Text] [Related]
20. A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis.
Xiao CY; Wang J; Zhang SZ; Van Hul W; Wuyts W; Qiu WM; Wu H; Zhang G
Br J Cancer; 2001 Jul; 85(2):176-81. PubMed ID: 11461073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
